1 Pewzner-Jung, Y, "When do Lasses (longevity assurance genes) become CerS (ceramide synthases)?: Insights into the regulation of ceramide synthesis" 281 : 25001-, 2006
2 Tafesse, F. G, "The multigenic sphingomyelin synthase family" 281 : 29421-, 2006
3 Hakomori, S, "The hapten structure of a developmentally regulated glycolipid antigen (SSEA-1) isolated from human erythrocytes and adenocarcinoma: a preliminary note" 100 : 1578-, 1981
4 Chakrabandhu, K, "The extracellular glycosphingolipid-binding motif of Fas defines its internalization route, mode and outcome of signals upon activation by ligand" 15 : 1824-, 2008
5 Hannun, Y. A, "The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind" 277 : 25847-, 2002
6 Wijesinghe, D. S, "Substrate specificity of human ceramide kinase" 46 : 2706-, 2005
7 Levery, S. B, "Structure elucidation of sphingolipids from the mycopathogen Paracoccidioides brasiliensis: an immunodominant betagalactofuranose residue is carried by a novel glycosylinositol phosphorylceramide antigen" 37 : 8764-, 1998
8 Hakomori, S. I, "Structure and function of glycosphingolipids and sphingolipids: recollections and future trends" 1780 : 325-, 2008
9 Zama, K, "Simultaneous quantification of glucosylceramide and galactosylceramide by normal-phase HPLC using O-phtalaldehyde derivatives prepared with sphingolipid ceramide N-deacylase" 19 : 767-, 2009
10 Zhang, X, "Review: Glycosphingolipids in health and disease" 34 : 3-, 2004
1 Pewzner-Jung, Y, "When do Lasses (longevity assurance genes) become CerS (ceramide synthases)?: Insights into the regulation of ceramide synthesis" 281 : 25001-, 2006
2 Tafesse, F. G, "The multigenic sphingomyelin synthase family" 281 : 29421-, 2006
3 Hakomori, S, "The hapten structure of a developmentally regulated glycolipid antigen (SSEA-1) isolated from human erythrocytes and adenocarcinoma: a preliminary note" 100 : 1578-, 1981
4 Chakrabandhu, K, "The extracellular glycosphingolipid-binding motif of Fas defines its internalization route, mode and outcome of signals upon activation by ligand" 15 : 1824-, 2008
5 Hannun, Y. A, "The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind" 277 : 25847-, 2002
6 Wijesinghe, D. S, "Substrate specificity of human ceramide kinase" 46 : 2706-, 2005
7 Levery, S. B, "Structure elucidation of sphingolipids from the mycopathogen Paracoccidioides brasiliensis: an immunodominant betagalactofuranose residue is carried by a novel glycosylinositol phosphorylceramide antigen" 37 : 8764-, 1998
8 Hakomori, S. I, "Structure and function of glycosphingolipids and sphingolipids: recollections and future trends" 1780 : 325-, 2008
9 Zama, K, "Simultaneous quantification of glucosylceramide and galactosylceramide by normal-phase HPLC using O-phtalaldehyde derivatives prepared with sphingolipid ceramide N-deacylase" 19 : 767-, 2009
10 Zhang, X, "Review: Glycosphingolipids in health and disease" 34 : 3-, 2004
11 Linn, S. C, "Regulation of de novo sphingolipid biosynthesis and the toxic consequences of its disruption" 29 : 831-, 2001
12 Vance, D. E, "Quantitative determination of the neutral glycosyl ceramides in human blood" 8 : 621-, 1967
13 Hannun, Y. A, "Principles of bioactive lipid signalling: lessons from sphingolipids" 9 : 139-, 2008
14 Hoffmann, P, "On the structural diversity of Shiga toxin glycosphingolipid receptors in lymphoid and myeloid cells determined by nanoelectrospray ionization tandem mass spectrometry" 24 : 2295-, 2010
15 Wheeler, S. F, "Negative ion mass spectrometry of sialylated carbohydrates: discrimination of Nacetylneuraminic acid linkages by MALDI-TOF and ESI-TOF mass spectrometry" 72 : 5027-, 2000
16 Coetzee, T, "Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability" 86 : 209-, 1996
17 Raas-Rothschild, A, "Glycosphingolipidoses: beyond the enzymatic defect" 21 : 295-, 2004
18 Yanagisawa, M, "Glycosphingolipid synthesis inhibitor represses cytokine-induced activation of the Ras-MAPK pathway in embryonic neural precursor cells" 138 : 285-, 2005
19 Ledeen, R. W, "Gangliosides: structure, isolation,and analysis" 83 : 139-, 1982
20 Causeret, C, "Further characterization of rat dihydroceramide desaturase: tissue distribution, subcellular localization, and substrate specificity" 35 : 1117-, 2000
21 Schwarz, A, "Distinct roles for ceramide and glucosylceramide at different stages of neuronal growth" 17 : 2929-, 1997
22 Kannagi, R, "Current relevance of incomplete synthesis and neo-synthesis for cancer-associated alteration of carbohydrate determinants--Hakomori's concepts revisited" 1780 : 525-, 2008
23 Deshmukh, G. D, "Abnormalities of glycosphingolipid, sulfatide,and ceramide in the polycystic (cpk/cpk) mouse" 35 : 1611-, 1994
24 Folch, J, "A simple method for the isolation and purification of total lipides from animal tissues" 226 : 497-, 1957
25 Bligh, E. G, "A rapid method of total lipid extraction and purification" 37 : 911-, 1959